|
 |
- When you have reached agreement with your cooperating scientist
at the institution providing the material for your research, obtain
their standard MTA form. In most cases, they should use the "Uniform
Biological Material Transfer Agreement" (UBMTA), which was
developed and maintained by the National Institutes of Health
for transfer of material among academic and non-profit research
institutions. If you are working with a commercial company, such
as a drug firm, they will have their own standard form. Copy the
form so that you have two clean copies, sign both—preferably
with an ink color other than black—in the space for the recipient
research scientist or principal investigator, and then create
the Material Transfer Agreement Routing Form (MTARF)—see
#2 below. Attach a brief description of the planned research
so we can best tailor the MTA terms to protect the research.
- To create an MTARF, go to the EGMS
homepage, select EGMS forms, log in, and select Make
request, then MTARF. To help you with filling-out the
form, press here
to download MTARF instructions to reference while you are on-line.
Press here for a sample
filled-out form to see what a completed MTARF looks like.
- Once the MTARF is completed and submitted by the principal investigator,
print a copy (it will say "Draft" on it until SPA has
accepted it).
- Please send or bring both signed copies of the MTA you received
from the material provider, along with the hard copy of the MTARF,
to the frony desk in the SPA office at 450 McNamara Alumni Center.
- The MTA coordinator will review the file and contact you if
more information is required. You may also be contacted for more
information during the process. You are encouraged to call 612-625-8826
at any time for a progress report on your MTA or if your needs
change. Click here
for things to watch out for in the MTA process.
- The MTA coordinator will review the terms of the MTA to see
how well the interests of the PI and the University are protected.
She or he will then negotiate directly with the other party to
conclude the MTA. The elapsed time required depends on the willingness
of the other party to negotiate and the timeliness of their actions.
These factors are out of the University's control. Most often,
the sticking point is intellectual property; if they have patented
the material, or the University has patents of its own related
to the proposed research, it may take some time to work through
an acceptable compromise. In very few instances, it may be
that you will decide not to use that material because the price
in terms of lost intellectual property rights or limits they place
on your research or ability to publish are simply unacceptable.
This most often happens when working with pharmaceutical developers
and manufacturers. None of these terms are problematic if the
other party is willing to use the UBMTA.
- Once both parties have agreed to the terms of the MTA, the MTA
will be sent to the material provider for signature and a copy
will be sent to you.
- When the MTA has been fully executed, you will receive a copy
of the signed MTA.
|
| |
For more
MTA information or assistance, contact:
Duane Oyen, MTA Coordinator,
at 612 625-8826
e-mail:
doyen@umn.edu
Mailing Address:
SPA MTA Coordinator, 450 McNamara Alumni Center
200 Oak Street SE, Minneapolis, MN 55455 |
|
